SCHEMBL21135507

SCHEMBL21135507

C/C=C(\N)C(=O)c1cccc(C)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.63
HDAC8 Q9BY41 1/20 0.50
HDAC6 Q9UBN7 1/20 0.50
SMN1; SMN2 Q16637 2/20 0.47
HPGD P15428 2/20 0.46
KCNK3 O14649 1/20 0.46
KCNH2 Q12809 1/20 0.46
KCNK9 Q9NPC2 1/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
POLB P06746 1/20 0.45
NPC1 O15118 4/20 0.43
RAB9A P51151 4/20 0.43
PKM P14618 2/20 0.43
CTSL P07711 1/20 0.43
CTSK P43235 1/20 0.43
HTT P42858 1/20 0.43
ALDH1A1 P00352 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10793079 0.82 PARP1 (0.70) PARP1HDAC8HDAC6SMN1; SMN2HPGD
SCHEMBL3753879 0.82 PARP1 (0.68) PARP1HDAC8HDAC6SMN1; SMN2HPGD
SCHEMBL13799999 0.78 PARP1 (1.00) PARP1HDAC8HDAC6SMN1; SMN2HPGD
SCHEMBL21335076 0.78 CES2 (0.56) PARP1SMN1; SMN2TDP1L3MBTL1POLB
SCHEMBL12798 0.78 PARP1 (1.00) PARP1HDAC8HDAC6SMN1; SMN2HPGD
SCHEMBL12287066 0.76 PARP1 (0.61) PARP1HDAC8HDAC6SMN1; SMN2HPGD
Hydrochloric Acid SCHEMBL4376573 0.76 PARP1 (0.96) PARP1HDAC8HDAC6SMN1; SMN2HPGD
SCHEMBL31529061 0.76 CES2 (0.65) PARP1HDAC8HDAC6SMN1; SMN2HPGD
Hydrochloric Acid SCHEMBL5089078 0.76 PARP1 (0.96) PARP1HDAC8HDAC6SMN1; SMN2HPGD
SCHEMBL29922789 0.76 PARP1 (0.61) PARP1HDAC8HDAC6SMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019113071-A1 COMPOSITIONS AND METHODS FOR TREATING ALK-MEDIATED CANCER ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) 2019-06-13 WO disclosed